Protective role of interleukin-10 promoter gene polymorphism in the pathogenesis of invasive pulmonary aspergillosis after allogeneic stem cell transplantation

Bone Marrow Transplantation

Volumn 36, Issue 12, 2005, Pages 1089-1095

  Seo, K W ^a   Kim, D H ^a   Sohn, S K ^a   Lee, N Y ^a   Chang, H H ^a   Kim, S W ^a   Jeon, S B ^a   Baek, J H ^a   Kim, J G ^a   Suh, J S ^a   Lee, K B ^a  

^a Kyungpook National University Hospital   (South Korea)

Author keywords

Allogeneic stem cell transplantation; Interleukin 10; Invasive pulmonary aspergillosis; Single nucleotide polymorphism

Indexed keywords

ACICLOVIR; AMPHOTERICIN B; BUSULFAN; CD34 ANTIGEN; CIPOL N; CIPROFLOXACIN; COTRIMOXAZOLE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; FLUCONAZOLE; FLUDARABINE; IDARUBICIN; IMMUNOGLOBULIN; INTERLEUKIN 10; ITRACONAZOLE; METHOTREXATE; METRONIDAZOLE; TACROLIMUS; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID;

ADOLESCENT; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; CORRELATION ANALYSIS; FEMALE; GENE FUNCTION; GENETIC POLYMORPHISM; HAPLOTYPE; HEMATOLOGIC MALIGNANCY; HLA MATCHING; HUMAN; INCIDENCE; INFECTION; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONBIOLOGICAL MODEL; PATHOGENESIS; PREDICTION; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VEIN OCCLUSION;

ADOLESCENT; ADULT; ANTIGENS, CD34; ASPERGILLOSIS; FEMALE; GRAFT VS HOST DISEASE; HAPLOTYPES; HLA ANTIGENS; HUMANS; INTERLEUKIN-10; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROPORTIONAL HAZARDS MODELS; STEM CELL TRANSPLANTATION; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 30544450276     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705181     Document Type: Article

References (29)

1. Latge JP. Aspergillus fumigatus and aspergillosis. Clin Microbiol Rev 1999; 12: 310-350.
2. Subira M, Martino R, Franquet T et al. Invasive pulmonary aspergillosis in patients with hematologic malignancies: Survival and prognostic factors. Haematologica 2002; 87: 528-534.
3. Ribaud P, Chastang C, Latge JP et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis 1999; 28: 322-330.
4. Latge JP. The pathobiology of Aspergillus fumigatus. Trends Microbiol 2001; 9: 382-389.
5. Nagai H, Guo J, Choi H et al. Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis. J Infect Dis 1995; 172: 1554-1560.
6. Roilides E, Dimitriadou-Georgiadou A, Sein T et al. Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus. Infect Immun 1998; 66: 5999-6003.
7. Lalani I, Bhol K, Ahmed AR. Interleukin-10: Biology, role in inflammation and autoimmunity. Ann Allergy Asthma Immunol 1997; 79: 469-483.
8. Fiorentino DF, Zlotnik A, Mosmann TR et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991; 147: 3815-3822.
9. Turner DM, Williams DM, Sankaran D et al. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet 1997; 24: 1-8.
10. Lin MT, Storer B, Martin PJ et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003; 349: 2201-2210.
11. Mullighan C, Heatley S, Doherty K et al. Non-HLA immunogenetic polymorphism and the risk of complications after allogeneic hemopoietic stem-cell transplantation. Transplantation 2004; 77: 587-596.
12. Kim DH, Lee NY, Sohn SK et al. IL-10 promoter gene polymorphism associated with the occurrence of chronic GVHD and its clinical course during systemic immunosuppressive treatment for chronic GVHD after allogeneic peripheral blood stem cell transplantation. Transplantation 2005; 79: 1615-1622.
13. Keen LJ, DeFor TE, Bidwell JL et al. Interleukin-10 and tumor necrosis factor alpha region haplotypes predict transplant-related mortality after unrelated donor stem cell transplantation. Blood 2004; 103: 3599-3602.
14. Strieter RM, Belperio JA, Keane MP. Host innate defenses in the lung: the role of cytokines. Curr Opin Infect Dis 2003; 16: 193-198.
15. Sohn SK, Kim JG, Sung WJ et al. Harvesting peripheral blood stem cells from healthy donors on 4th day of cytokine mobilization. J Clin Apheresis 2003; 18: 186-189.
16. Sohn SK, Jung JT, Kim DH et al. Prophylactic growth factor-primed donor lymphocyte infusion using cells reserved at the time of transplantation after allogeneic peripheral blood stem cell transplantation in patients with high-risk hematologic malignancies. Cancer 2002; 94: 18-24.
17. Przepiorka D, Weisdorf D, Martin P et al. 1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant 1995; 15: 825-828.
18. Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69: 204-217.
19. Jantunen E, Piilonen A, Volin L et al. Diagnostic aspects of invasive Aspergillus infections in allogeneic BMT recipients. Bone Marrow Transplant 2000; 25: 867-871.
20. Ascioglu S, Rex JH, de Pauw B et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus. Clin Infect Dis 2002; 34: 7-14.
21. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68: 978-989.
22. Roilides E, Dimitriadou A, Kadiltsoglou I et al. IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus. J Immunol 1997; 158: 322-329.
23. Clemons KV, Grunig G, Sobel RA et al. Role of IL-10 in invasive aspergillosis: Increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis. Clin Exp Immunol 2000; 122: 186-191.
24. Del Sero G, Mencacci A, Cenci E et al. Antifungal type 1 responses are upregulated in IL-10-deficient mice. Microbes Infect 1999; 1: 1169-1180.
25. Centeno-Lima S, Silveira H, Casimiro C et al. Kinetics of cytokine expression in mice with invasive aspergillosis: Lethal infection and protection. FEMS Immunol Med Microbiol 2002; 32: 167-173.
26. Roilides E, Sein T, Roden M et al. Elevated serum concentrations of interleukin-10 in nonneutropenic patients with invasive aspergillosis. J Infect Dis 2001; 183: 518-520.
27. Lim S, Crawley E, Woo P et al. Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet 1998; 352: 113.
28. Roh JW, Kim MH, Seo SS et al. Interleukin-10 promoter polymorphisms and cervical cancer risk in Korean women. Cancer Lett 2002; 184: 57-63.
29. Temple SE, Lim E, Cheong KY et al. Alleles carried at positions -819 and -592 of the IL10 promoter affect transcription following stimulation of peripheral blood cells with Streptococcus pneumoniae. Immunogenetics 2003; 55: 629-632.